Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where ROFLUMILAST was used for Dermatitis.

Most Reported Side Effects for ROFLUMILAST

Side Effect Reports % Deaths Hosp.
Death 569 21.1% 568 8
Dyspnoea 433 16.0% 7 191
Chronic obstructive pulmonary disease 292 10.8% 26 158
Diarrhoea 265 9.8% 6 82
Off label use 242 9.0% 7 65
Weight decreased 224 8.3% 8 74
Nausea 191 7.1% 5 36
Pneumonia 176 6.5% 7 123
Headache 166 6.2% 2 26
Malaise 164 6.1% 6 48
Asthma 158 5.9% 0 76
Drug ineffective 156 5.8% 1 30
Decreased appetite 151 5.6% 6 44
Insomnia 151 5.6% 2 29
Cough 140 5.2% 0 40

Other Indications for ROFLUMILAST

Chronic obstructive pulmonary disease (945) Product used for unknown indication (369) Psoriasis (149) Seborrhoeic dermatitis (61) Emphysema (40) Asthma (27) Pseudomonas infection (27) Dermatitis atopic (26) Dyspnoea (22) Eczema (15)

Other Drugs Used for Dermatitis

DUPILUMAB (9,959) CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50)

Related Pages

ROFLUMILAST Full Profile All Dermatitis Drugs ROFLUMILAST Demographics ROFLUMILAST Timeline